Parameters (mmol/l) Е2Е3 Е3Е3 Е2Е4 Е3Е4 Е4Е4
TC (mmol/l) 4.82 ± 0.07 5.0 ± 0.05 5.4 ± 0.09* 5.7 ± 0.06* 5.9 ± 0.09*
HDLC 0.93 ± 0.04 0.92 ± 0.02 0.90 ± 0.07 0.91 ± 0.03 0.90 ± 0.06
TG 2.2 ± 0.06 2.1 ± 0.07 2.3 ± 0.10 2.4 ± 0.08 2.3 ± 0.15
LDLC 3.45 ± 0.08 3.66 ± 0.05 4.04 ± 0.19* 4.31 ± 0.07* 4.54 ± 0.14*
VLDLPC 0.44 ± 0.03 0.42 ± 0.01 0.46 ± 0.11 0.48 ± 0.03 0.46 ± 0.10
AI (relative unit) 4.18 ± 0.18 4.43 ± 0.13 5.0 ± 0.26* 5.26 ± 0.15* 5.56 ± 0.22*
Apo А1 (mg/dl)     139.5 ± 3.6 138.6 ± 2.3 138.4 ± 4.3 137.9 ± 3.2 136.3 ± 5.5
Apo В (mg/dl)     104.1 ± 3.8 105.1 ± 2.4 103.1 ± 4.4 100.2 ± 2.9 101.9 ± 4.2
Apo Е (mg/dl)     6.6+0.32 6.8 ± 0.25 6.4 ± 0.48 6.3 ± 0.28 6.2 ± 0.40
*р< 0,05
Table 9: Genotypes of the Apo E Gene and Parameters of the Lipid and Apolipoprotein Spectrum in the Kazakhs with Coronary Heart Disease (CHD)